Narrow Gauge Ventures
Venture capitalAnn Arbor · Seed–Series A · 1 people tracked
Investment thesis
Narrow Gauge Ventures is an early-stage venture fund that invests in healthcare efficiency companies operating across the United States.
Team · 1 people
from the firm's websiteFrequently asked questions
- What stage does Narrow Gauge Ventures invest at?
- Narrow Gauge Ventures invests at the Seed, Series A stages.
- What is Narrow Gauge Ventures's typical check size?
- Narrow Gauge Ventures typically writes checks of $100K – $500K.
- What sectors does Narrow Gauge Ventures focus on?
- Narrow Gauge Ventures focuses on Enterprise Software, Healthtech, SaaS.
- Where is Narrow Gauge Ventures located?
- Narrow Gauge Ventures is headquartered in Ann Arbor, US.
Similar investors
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.